Mark Hahn
Director of Finance/CFO at VERONA PHARMA PLC
Net worth: 129 M $ as of 30/03/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Zaccardelli | M | 59 |
Cempra, Inc.
 Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | 8 years |
| Thong Le | M | 48 | - | |
| Mahendra Shah | M | 79 | 8 years | |
| Carl T. Foster | M | 59 |
Cempra Pharmaceuticals, Inc.
 Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC.
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | 14 years |
| Lisa Deschamps | F | 52 | 3 years | |
| Vikas Sinha | M | 60 | 8 years | |
| Eugene Yeo | M | 47 | - | |
| Ostra Jewell | F | - | 5 years | |
| Andras Forgacs | M | 48 | - | |
| Stephanie C. Read | F | 48 | - | |
| Victoria Stewart | F | - | 5 years | |
| Sven Anders Ullman | M | 68 | 9 years | |
| Martin Edwards | M | 68 | 5 years | |
| Christopher Martin | M | - |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | 6 years |
| James Brady | M | 61 | 2 years | |
| Ken Cunningham Cunningham | M | 71 | 9 years | |
| David Ebsworth | M | 69 | 10 years | |
| Ian Howes | M | 66 | - | |
| Caroline Diaz | F | - | 3 years | |
| Mahmood Ladha | M | 60 | 5 years | |
| Michael Austwick | M | 54 | - | |
| Kavita Aggarwal | M | - | 1 years | |
| Tara Rheault | M | 49 | 5 years | |
| Bill L. Nichols | M | - | 6 years | |
| Ben Harber | M | 47 | - | |
| Per Richard Torbjörn Hallberg | M | 55 | 5 years | |
| Christina Ackermann | F | 59 | 1 years | |
| Matthew Casbon | M | - | 2 years | |
| Kevin Chow | M | 54 | - | |
| Kathleen Rickard | M | 65 | 5 years | |
| Angela Paulovits | F | - |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | 13 years |
| Jessica Burback | F | - | - | |
| Guido Oelkers | M | 59 | 5 years | |
| Sundar Kodiyalam | M | 62 | - | |
| Kendall Mohler | M | 68 | - | |
| Henrik Stenqvist | M | 57 | 5 years | |
| Bruce Carter | M | 80 | - | |
| Rettenmier Suzanne | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Prabhavathi Fernandes | M | 74 |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC.
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | 11 years |
| Paul Sherrill Neff | M | 72 |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC.
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | 6 years |
| Louis S. Slaughter | M | - | 4 years | |
| David Gill | M | 69 |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC.
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | 8 years |
| Douglas Blankenship | M | 62 | 1 years | |
| Alexander Sapir | M | 57 | 2 years | |
| Jeff N. Hunter | M | - | 5 years | |
| Rick S. Kent | M | 74 |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC.
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | - |
| Paul Manning | M | 68 | 3 years | |
| Rick Corry | M | - |
BuildLinks, Inc.
 BuildLinks, Inc. Packaged SoftwareTechnology Services BuildLinks, Inc. develops construction management and scheduling software for home builders. Its software serves as an enterprise-wide data platform that coordinates trade partners, purchasing and supply chain with construction and design center activities. The firm also provides implementation, client service, and resources. The company was founded in 2000 and is headquartered in Morrisville, NC. | - |
| Claire Poll | F | 57 | 18 years | |
| Michael Dougherty | M | 66 |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | 4 years |
| I. Wistar Morris | M | - |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | - |
| Chip Gillooly | M | - |
BuildLinks, Inc.
BuildLinks, Inc. Packaged SoftwareTechnology Services BuildLinks, Inc. develops construction management and scheduling software for home builders. Its software serves as an enterprise-wide data platform that coordinates trade partners, purchasing and supply chain with construction and design center activities. The firm also provides implementation, client service, and resources. The company was founded in 2000 and is headquartered in Morrisville, NC. | 2 years |
| David Oldach | M | 66 |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC.
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | 6 years |
| Jane Anderson | F | - |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | - |
| David S. Moore | M | 50 |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | 5 years |
| Ammar Malhas | M | 64 |
University of Wisconsin-Milwaukee
| 5 years |
| Steven M. Goldman | M | 72 | 2 years | |
| John D. Bluth | M | - |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | - |
| Peter Skanavis | M | - |
University of Wisconsin-Milwaukee
| 10 years |
| Alfred Novak | M | 76 | 2 years | |
| Roger Jeffs | M | 62 | 2 years | |
| Nancy Wysenski | F | 66 | 1 years | |
| Rishi Gupta | M | 46 | 8 years | |
| Alan Hoffmann | M | 63 |
University of Wisconsin-Milwaukee
| 4 years |
| Siva Yam | M | - |
University of Wisconsin-Milwaukee
| 3 years |
| Richard Hennings | M | - | 3 years | |
| Nancy Herje | F | - | - | |
| Sam Khoury | M | 69 |
University of Wisconsin-Milwaukee
| 2 years |
| Judy Heun | F | 57 |
University of Wisconsin-Milwaukee
| 4 years |
| Jason Hoitt | M | 46 | 1 years | |
| Desiree Luthman | M | 65 | 4 years | |
| Dov Goldstein | M | 56 |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | 4 years |
| Patrick John Retzer | M | - |
University of Wisconsin-Milwaukee
| 1 years |
| George E. Kiemle | M | 76 |
BuildLinks, Inc.
BuildLinks, Inc. Packaged SoftwareTechnology Services BuildLinks, Inc. develops construction management and scheduling software for home builders. Its software serves as an enterprise-wide data platform that coordinates trade partners, purchasing and supply chain with construction and design center activities. The firm also provides implementation, client service, and resources. The company was founded in 2000 and is headquartered in Morrisville, NC. | - |
| Salvatore S. Bentivegna | M | - | - | |
| Timothy G. Schaefer | M | - |
University of Wisconsin-Milwaukee
| 4 years |
| Mary Stanek | F | 67 |
University of Wisconsin-Milwaukee
| 2 years |
| Jeri Harman | F | 66 |
University of Wisconsin-Milwaukee
| 4 years |
| Sean Stalfort | M | 54 | 3 years | |
| Imad Mohammad Abdel Khaleq | M | 61 |
University of Wisconsin-Milwaukee
| 4 years |
| Walter J. Kunicki | M | - |
University of Wisconsin-Milwaukee
| 4 years |
| Drusilla Scott | M | 70 |
Cempra Pharmaceuticals, Inc.
Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | 10 years |
| David Gregory Herro | M | - |
University of Wisconsin-Milwaukee
| 1 years |
| Iggy Smetek | M | - |
University of Wisconsin-Milwaukee
| 4 years |
| Edwin C. Ciskowski | M | - |
University of Wisconsin-Milwaukee
| 4 years |
| Chris M. Austen | M | - |
BuildLinks, Inc.
BuildLinks, Inc. Packaged SoftwareTechnology Services BuildLinks, Inc. develops construction management and scheduling software for home builders. Its software serves as an enterprise-wide data platform that coordinates trade partners, purchasing and supply chain with construction and design center activities. The firm also provides implementation, client service, and resources. The company was founded in 2000 and is headquartered in Morrisville, NC. | - |
| David Moskowitz | M | - | 1 years | |
| Kenneth Touw | M | 76 |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Cempra, Inc. engages as a clinical-stage pharmaceutical company, which focuses on the development of antibacterials to meet critical medical needs. Its products include; Solithromycin and Taksta. The company was founded by Prabhavathi B. Fernandes on November 18, 2005 and is headquartered in Chapel Hill, NC. | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 54 | 61.36% |
| United Kingdom | 26 | 29.55% |
| Cayman Islands | 11 | 12.50% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Mark Hahn
- Personal Network
